Explore scientific data around our next generation products. Use the filters below to narrow things down, or simply search via keyword.
Mechanistic New Approach Methodologies Identify Substantial Reductions in Cardiovascular Relevant Biological Activity from E‑Vapour Products Compared to Cigarettes
ViewAssessing Innovation in Nicotine Pouches In Vitro Evidence Supporting Reduced Toxicological Activity of New Pouch Substrate Blend
ViewMultiple In Vitro Bioassays Support Reduced Toxicological Potential of Pulze iSENZIA and iD Aerosols Relative 1R6F Cigarette Smoke
Viewblu bar® kit aerosol showed substantially lower biological activity in CORESTA and ToxTracker®in vitro assays compared to cigarette smoke
ViewComparative Assessment of PULZE Heated Tobacco and Herbal Aerosols Demonstrates Substantially Lower Toxicant Levels on Average than Cigarette Smoke
ViewToxicological Evaluation of blu Bar Kit Aerosol Compared with Cigarette Smoke: Evidence as part of Responsible Product Stewardship
ViewIntegrated aerosol chemistry and in vitro assessment provide a foundation for an evidence-based, responsible product development framework
ViewIn vitro assessment of Tobacco-Free Nicotine Pouches reveals marked reductions in toxicity when compared to cigarettes
ViewOral Immune CoCulture Model Reveals Significantly Lower Toxicity of Tobacco free Nicotine Pouches Compared to Cigarettes
ViewChemical characterisation of nicotine pouches and comparison to combustible cigarettes
View